GameStop (GME): Notes From The Road - Macquarie
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Macquarie analyst, Ben Schachter, reiterated his Outperform rating on shares of GameStop (NYSE: GME) after taking management on the road to meet investors on 10/13. The analyst remains positive on GME going into the holiday season, when he expects the video game business to perform in-line and believe investors are increasingly interested in GME’s diversification efforts.
Management remains dedicated to cash returns and expects to buy back $76- 125mm stock in the back half of the year, and in meetings reiterated their commitment to annual dividend increases as well as returning excess cash to shareholders via buybacks.
The analyst believes the stock is still attractive based on its cash generation profile and valuation, however near-term title launches will be key for FY’16.
No change to the price target of $36.
Shares of GameStop closed at $25.47 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Skyworks Solutions (SWKS) PT Raised to $105 at Oppenheimer Following 1Q Report
- UPDATE: SunTrust Robinson Humphrey Downgrades Pennsylvania Real Estate Investment Trust (PEI) to Hold
- PacWest Bancorp (PACW) PT Raised to $60.50 at FIG Partners Following 4Q Report
Create E-mail Alert Related CategoriesAnalyst Comments
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!